Mutations in genes such as CHRDL2, STC1, CTGF, GDNF, and FGF7; which are involved in liver fibrosis and inflammation were highlighted, shedding light on their potential role in advancing MASLD towards more severe stages, including liver cirrhosis and hepatocellular carcinoma (HCC). Here, FGF7 is linked to hepatocellular carcinoma.